304 related articles for article (PubMed ID: 24650975)
1. Nodular lymphocyte predominant hodgkin lymphoma: biology, diagnosis and treatment.
Goel A; Fan W; Patel AA; Devabhaktuni M; Grossbard ML
Clin Lymphoma Myeloma Leuk; 2014 Aug; 14(4):261-70. PubMed ID: 24650975
[TBL] [Abstract][Full Text] [Related]
2. [Nodular lymphocyte-predominant Hodgkin lymphoma in children: clinical course, biology, and management].
Gorde-Grosjean S; Guimard G; Lambilliotte A; Coulomb-Lhermine A; Montravers F; Landman-Parker J
Bull Cancer; 2014 Sep; 101(9):881-90. PubMed ID: 25296072
[TBL] [Abstract][Full Text] [Related]
3. CD20-Negative Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A 20-Year Consecutive Case Series From a Tertiary Cancer Center.
Menke JR; Spinner MA; Natkunam Y; Warnke RA; Advani RH; Gratzinger DA
Arch Pathol Lab Med; 2021 Jun; 145(6):753-758. PubMed ID: 32991677
[TBL] [Abstract][Full Text] [Related]
4. Nodular lymphocyte predominant Hodgkin lymphoma in children and adolescents--a comprehensive review of biology, clinical course and treatment options.
Shankar A; Daw S
Br J Haematol; 2012 Nov; 159(3):288-98. PubMed ID: 22994199
[TBL] [Abstract][Full Text] [Related]
5. Modern management of lymphocyte-predominant Hodgkin lymphoma.
Xing KH; Savage KJ
Br J Haematol; 2013 May; 161(3):316-29. PubMed ID: 23398605
[TBL] [Abstract][Full Text] [Related]
6. Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) with CD30-positive lymphocyte-predominant (LP) cells.
Seliem RM; Ferry JA; Hasserjian RP; Harris NL; Zukerberg LR
J Hematop; 2011 Sep; 4(3):175. PubMed ID: 32288859
[TBL] [Abstract][Full Text] [Related]
7. Nodular lymphocyte-predominant hodgkin lymphoma.
Tsai HK; Mauch PM
Semin Radiat Oncol; 2007 Jul; 17(3):184-9. PubMed ID: 17591565
[TBL] [Abstract][Full Text] [Related]
8. Lymphocyte-Rich Classical Hodgkin Lymphoma. A Case with Difficulty in Distinguishing from Nodular Lymphocyte-Predominant Hodgkin Lymphoma.
Sakai J; Tanae K; Takahashi N; Nagata K; Yoshino T; Tamaru J; Niitsu N
J Clin Exp Hematop; 2015; 55(1):23-8. PubMed ID: 26106003
[TBL] [Abstract][Full Text] [Related]
9. Biology, clinical course and management of nodular lymphocyte-predominant hodgkin lymphoma.
Nogová L; Rudiger T; Engert A
Hematology Am Soc Hematol Educ Program; 2006; ():266-72. PubMed ID: 17124071
[TBL] [Abstract][Full Text] [Related]
10. Nodular lymphocyte predominant Hodgkin lymphoma.
Lee AI; LaCasce AS
Oncologist; 2009 Jul; 14(7):739-51. PubMed ID: 19605845
[TBL] [Abstract][Full Text] [Related]
11. Nodular lymphocyte-predominant Hodgkin lymphoma.
Savage KJ; Mottok A; Fanale M
Semin Hematol; 2016 Jul; 53(3):190-202. PubMed ID: 27496311
[TBL] [Abstract][Full Text] [Related]
12. Follicular peripheral T-cell lymphoma expands the spectrum of classical Hodgkin lymphoma mimics.
Moroch J; Copie-Bergman C; de Leval L; Plonquet A; Martin-Garcia N; Delfau-Larue MH; Molinier-Frenkel V; Belhadj K; Haioun C; Audouin J; Swerdlow SH; Marafioti T; Gaulard P
Am J Surg Pathol; 2012 Nov; 36(11):1636-46. PubMed ID: 23073322
[TBL] [Abstract][Full Text] [Related]
13. B-cell transcription factors Pax-5, Oct-2, BOB.1, Bcl-6, and MUM1 are useful markers for the diagnosis of nodular lymphocyte predominant Hodgkin lymphoma.
Herbeck R; Teodorescu Brînzeu D; Giubelan M; Lazăr E; Dema A; Ioniţă H
Rom J Morphol Embryol; 2011; 52(1):69-74. PubMed ID: 21424034
[TBL] [Abstract][Full Text] [Related]
14. Primary cutaneous follicle center lymphoma with Hodgkin and Reed-Sternberg-like cells: a new histopathologic variant.
Dilly M; Ben-Rejeb H; Vergier B; Feldis M; Toty L; Nohra O; Beylot-Barry M; Gros A; Merlio JP; Parrens M
J Cutan Pathol; 2014 Oct; 41(10):797-801. PubMed ID: 25099172
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus-positive nodular lymphocyte predominant Hodgkin lymphoma.
Wang S; Medeiros LJ; Xu-Monette ZY; Zhang S; O'Malley DP; Orazi A; Zuo Z; Bueso-Ramos CE; Yin CC; Liu Z; Miranda RN; Young KH
Ann Diagn Pathol; 2014 Aug; 18(4):203-9. PubMed ID: 24852241
[TBL] [Abstract][Full Text] [Related]
16. J chain and myocyte enhancer factor 2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.
Moore EM; Swerdlow SH; Gibson SE
Hum Pathol; 2017 Oct; 68():47-53. PubMed ID: 28851661
[TBL] [Abstract][Full Text] [Related]
17. EBV-positive nodular lymphocyte predominant Hodgkin lymphoma: a single institution experience.
Fei F; Kiruthiga KG; Younes S; Natkunam Y
Hum Pathol; 2022 Nov; 129():32-39. PubMed ID: 35987347
[TBL] [Abstract][Full Text] [Related]
18. The emerging role for rituximab in the treatment of nodular lymphocyte predominant Hodgkin lymphoma.
Maeda LS; Advani RH
Curr Opin Oncol; 2009 Sep; 21(5):397-400. PubMed ID: 19606035
[TBL] [Abstract][Full Text] [Related]
19. How I treat nodular lymphocyte-predominant Hodgkin lymphoma.
Eichenauer DA; Engert A
Blood; 2020 Dec; 136(26):2987-2993. PubMed ID: 32877522
[TBL] [Abstract][Full Text] [Related]
20. Intrafollicular classical Hodgkin lymphoma mimicking nodular lymphocyte predominant Hodgkin lymphoma: a report of two cases.
Tatsuno M; Maeshima AM; Kim SW; Maruyama D; Taniguchi H; Miyamoto K; Fukuhara S; Kobayashi Y; Tobinai K; Kushima R
Pathol Int; 2014 Dec; 64(12):613-7. PubMed ID: 25394195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]